Teleflex Incorporated risk profile
65 Stretched several inputs deteriorating together
Measured 21 October 2026 from TFX's filed statements. Recomputed nightly.
65 (Stretched), driven by Competitive position at 78, over 6 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 33 | Normal | Stable | One-year price volatility — 40.1% |
| Operating pressure | 59 | Elevated | Easing | Operating-margin drift — -12.0 percentage points |
| Cash conversion | 70 | Stretched | Worsening | Capital spending against operating cash — 0.99x |
| Leverage and coverage | 70 | Stretched | Worsening | Net debt to EBITDA — 7.64x |
| Competitive position | 78 | Stretched | Stable | Revenue-growth gap against peers — -59.9 percentage points |
| Concentration | 56 | Elevated | Stable | Geographic concentration — 4,229 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 33Johnson & Johnson 39Abbvie Inc 57Unitedhealth Group Inc 43Roche Holding AG 35Merck & Co Inc 35Novartis AG 29Novartis AG 31Astrazeneca plc 33Thermo Fisher Scientific Inc 44AMGEN Inc 47Gilead Sciences Inc 51
Financials, valuation and price history for Teleflex Incorporated